The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies.

Read More:
Solvanix set up to commercialise novel antibody-stabilisation technology

Leave a Reply